Herceptin was the first, the US Food and Drug Administration says at its consumer updates page. In 1998, the agency approved the drug to treat certain breast cancers, but there had to be a diagnostic to determine what type of breast cancer a patient had. Now, the agency adds, there are 19 cleared or approved companion diagnostic tests for a range of drugs to treat certain diseases and conditions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.